Affiliations 

  • 1 The Coca-Cola Company, Atlanta, GA 30313, USA. iprakash@coca-cola.com
  • 2 The Coca-Cola Company, Atlanta, GA 30313, USA. cbunders@coca-cola.com
  • 3 AMRI-Albany, Analytical Development, Albany, NY 12212, USA. Krishna.Devkota@amriglobal.com
  • 4 AMRI-Albany, Analytical Development, Albany, NY 12212, USA. Romila.Charan@amriglobal.com
  • 5 AMRI-Albany, Analytical Development, Albany, NY 12212, USA. Catherine.Ramirez@amriglobal.com
  • 6 AMRI-Albany, Analytical Development, Albany, NY 12212, USA. Christopher.Priedemann@amriglobal.com
  • 7 PureCircle Limited, Lengkuk Teknologi, Bandar Enstek, Negeri Sembilan 71760, Malaysia. avetik@purecircle.com
Biomolecules, 2014;4(2):374-89.
PMID: 24970220 DOI: 10.3390/biom4020374

Abstract

A minor product, rebaudioside M2 (2), from the bioconversion reaction of rebaudioside A (4) to rebaudioside D (3), was isolated and the complete structure of the novel steviol glycoside was determined. Rebaudioside M2 (2) is considered an isomer of rebaudioside M (1) and contains a relatively rare 1→6 sugar linkage. It was isolated and characterized with NMR (1H, 13C, COSY, HSQC-DEPT, HMBC, 1D-TOCSY, and NOESY) and mass spectral data. Additionally, we emphasize the importance of 1D and 2D NMR techniques when identifying complex steviol glycosides. Numerous NMR spectroscopy studies of rebaudioside M (1), rebaudioside D (3), and mixture of 1 and 3 led to the discovery that SG17 which was previously reported in literature, is a mixture of rebaudioside D (3), rebaudioside M (1), and possibly other related steviol glycosides.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.